Prognosis data chemotherapy cancer regional perfusion. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Lung Heart Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Lymph Nodes Breast

Organisms3

Dogs Mice, Nude Mice, SCID

Diseases60

Breast Neoplasms Lung Neoplasms Ovarian Neoplasms Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Stomach Neoplasms Carcinoma, Non-Small-Cell Lung Colonic Neoplasms Colorectal Neoplasms Neoplasm Invasiveness Disease Progression Adenocarcinoma Prostatic Neoplasms Pancreatic Neoplasms Carcinoma, Squamous Cell Carcinoma Liver Neoplasms Brain Neoplasms Bone Neoplasms Testicular Neoplasms Urinary Bladder Neoplasms Esophageal Neoplasms Uterine Cervical Neoplasms Rectal Neoplasms Head and Neck Neoplasms Recurrence Lymphatic Metastasis Lymphoma, Non-Hodgkin Neutropenia Peritoneal Neoplasms Nausea Hodgkin Disease Vomiting Genetic Predisposition to Disease Neoplasms, Germ Cell and Embryonal Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Neovascularization, Pathologic Endometrial Neoplasms Melanoma Sarcoma Lymphoma Skin Neoplasms Cell Transformation, Neoplastic Osteosarcoma Disease Models, Animal Precursor Cell Lymphoblastic Leukemia-Lymphoma Gastrointestinal Neoplasms Genital Neoplasms, Female Mouth Neoplasms Neoplasms, Hormone-Dependent Leukemia, Myeloid, Acute Kidney Neoplasms Carcinoma, Hepatocellular Germinoma Acute Disease Neoplasms, Multiple Primary Leukopenia Neoplasm, Residual

Chemicals and Drugs60

Nitrogen Radioisotopes Antineoplastic Agents Cisplatin Cyclophosphamide Doxorubicin Tumor Markers, Biological Etoposide Paclitaxel Methotrexate Taxoids Carboplatin Deoxycytidine Antimetabolites, Antineoplastic Vinblastine Organoplatinum Compounds Neoplasm Proteins Antineoplastic Agents, Phytogenic Receptor, erbB-2 Receptors, Estrogen Radiopharmaceuticals Antineoplastic Agents, Alkylating Bleomycin Anthracyclines Cancer Vaccines Ifosfamide Antibiotics, Antineoplastic RNA, Messenger Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Tumor Suppressor Protein p53 Cytarabine Camptothecin Tamoxifen Receptors, Progesterone DNA, Neoplasm Technetium Tc 99m Sestamibi Contrast Media Melphalan Antineoplastic Agents, Hormonal Organotechnetium Compounds Mitomycin RNA, Small Interfering Antigens, Neoplasm Dacarbazine Granulocyte Colony-Stimulating Factor Receptor, Epidermal Growth Factor Tegafur Mitoxantrone Carmustine Ki-67 Antigen Prostate-Specific Antigen Lomustine Thiotepa Platinum Compounds Antiemetics Quinazolines Bridged Compounds Tumor Suppressor Proteins Fluorouracil Daunorubicin

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Chemotherapy, Cancer, Regional Perfusion Perfusion Prognosis Antineoplastic Combined Chemotherapy Protocols Ventilation-Perfusion Ratio Microspheres Chemotherapy, Adjuvant Tomography, Emission-Computed, Single-Photon Tomography, Emission-Computed Perfusion Imaging Positron-Emission Tomography Feasibility Studies Combined Modality Therapy Treatment Outcome Survival Analysis Survival Rate Myocardial Perfusion Imaging Neoplasm Staging Disease-Free Survival Follow-Up Studies Early Detection of Cancer Prospective Studies Neoadjuvant Therapy Drug Administration Schedule Kaplan-Meier Estimate Predictive Value of Tests Retrospective Studies Multivariate Analysis Sensitivity and Specificity Tomography, X-Ray Computed Risk Factors Clinical Trials as Topic Immunohistochemistry Induction Chemotherapy Radiotherapy Risk Assessment Radiotherapy, Adjuvant Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Reproducibility of Results Salvage Therapy Palliative Care Risk Magnetic Resonance Imaging Neoplasm Transplantation Infusions, Intravenous Registries Tumor Burden Transplantation, Autologous Radiotherapy Dosage Neoplasm Grading Blotting, Western Proportional Hazards Models Cohort Studies Hyperthermia, Induced Drug Screening Assays, Antitumor Infusions, Intra-Arterial Odds Ratio Transplantation, Heterologous Mastectomy Molecular Targeted Therapy Oligonucleotide Array Sequence Analysis Pilot Projects Immunoenzyme Techniques Polymerase Chain Reaction Tissue Array Analysis Biopsy Drug Therapy Disease Models, Animal Incidence Chemoradiotherapy Models, Biological Hematopoietic Stem Cell Transplantation SEER Program Clinical Trials, Phase III as Topic Logistic Models Lymph Node Excision Immunotherapy Questionnaires Fatal Outcome Analysis of Variance Flow Cytometry Actuarial Analysis Gastrectomy Chi-Square Distribution Drug Delivery Systems Magnetic Resonance Angiography Confidence Intervals

Psychiatry and Psychology1

Phenomena and Processes31

Ventilation-Perfusion Ratio Coronary Circulation Pulmonary Circulation Regional Blood Flow Cerebrovascular Circulation Hemodynamics Drug Resistance, Neoplasm Time Factors Gene Expression Regulation, Neoplastic Sensitivity and Specificity Dose-Response Relationship, Drug Risk Mutation Apoptosis Cell Survival Genetic Predisposition to Disease Cell Proliferation Odds Ratio DNA Methylation Genotype Drug Synergism Microcirculation Down-Regulation Cell Division Cell Cycle Cell Movement Signal Transduction Chi-Square Distribution Up-Regulation Genes, p53 Polymorphism, Genetic

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science6

Survival Rate Registries Incidence SEER Program Questionnaires Fatal Outcome

Named Groups1

Health Care35

Feasibility Studies Treatment Outcome Survival Analysis Survival Rate Disease-Free Survival Follow-Up Studies Prospective Studies Kaplan-Meier Estimate Predictive Value of Tests Retrospective Studies Multivariate Analysis Sensitivity and Specificity Risk Factors Clinical Trials as Topic Risk Assessment Age Factors Reproducibility of Results Palliative Care Risk Registries Proportional Hazards Models Cohort Studies Odds Ratio National Cancer Institute (U.S.)Pilot Projects Incidence SEER Program Clinical Trials, Phase III as Topic Logistic Models Questionnaires Fatal Outcome Analysis of Variance Actuarial Analysis Chi-Square Distribution Confidence Intervals

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Chemotherapy, Cancer, Regional Perfusion Perfusion Nitrogen Radioisotopes Prognosis Antineoplastic Combined Chemotherapy Protocols Ventilation-Perfusion Ratio Coronary Circulation Pulmonary Circulation Microspheres Chemotherapy, Adjuvant Tomography, Emission-Computed, Single-Photon Regional Blood Flow Tomography, Emission-Computed Dogs Perfusion Imaging Cerebrovascular Circulation Positron-Emission Tomography Feasibility Studies Antineoplastic Agents Combined Modality Therapy Breast Neoplasms Treatment Outcome Cisplatin Survival Analysis Hemodynamics Lung Neoplasms Survival Rate Myocardial Perfusion Imaging Lung Neoplasm Staging Disease-Free Survival Heart Cyclophosphamide Doxorubicin Follow-Up Studies Ovarian Neoplasms Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Early Detection of Cancer Stomach Neoplasms Tumor Markers, Biological Prospective Studies Drug Resistance, Neoplasm Neoadjuvant Therapy Etoposide Drug Administration Schedule Carcinoma, Non-Small-Cell Lung Time Factors Kaplan-Meier Estimate Paclitaxel Colonic Neoplasms Colorectal Neoplasms Gene Expression Regulation, Neoplastic Neoplasm Invasiveness Disease Progression Adenocarcinoma Prostatic Neoplasms Pancreatic Neoplasms Cell Line, Tumor Carcinoma, Squamous Cell Carcinoma Methotrexate Taxoids Carboplatin Predictive Value of Tests Liver Neoplasms Deoxycytidine Retrospective Studies Multivariate Analysis Antimetabolites, Antineoplastic Mice, Nude Vinblastine Organoplatinum Compounds Neoplasm Proteins Sensitivity and Specificity Antineoplastic Agents, Phytogenic Receptor, erbB-2 Tomography, X-Ray Computed Risk Factors Clinical Trials as Topic Receptors, Estrogen Dose-Response Relationship, Drug Brain Neoplasms Immunohistochemistry Bone Neoplasms Induction Chemotherapy Radiotherapy Risk Assessment Radiotherapy, Adjuvant Age Factors Radiopharmaceuticals Testicular Neoplasms Antineoplastic Agents, Alkylating Urinary Bladder Neoplasms Bleomycin Gene Expression Profiling Anthracyclines Reverse Transcriptase Polymerase Chain Reaction Esophageal Neoplasms

No FAQ available that match "prognosis data chemotherapy cancer regional perfusion"